Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell R C Buchanan

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Clinical Rheumatology|October 20, 2023
Exploring the patient experience in polymyalgia rheumaticaGeorgia K Harris, Jessica L Leung, Russell R C Buchanan
Clinical Rheumatology|February 2, 2010
Tumour necrosis factor inhibitor-related lupus: safety of switching agentsJessica M T Luong, Boon T Tan, Russell R C Buchanan, et al.
Immunology|May 22, 2003
Soluble FcgammaRIIa inhibits rheumatoid factor binding to immune complexesBruce D Wines, Amanda Gavin, Maree S Powell, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 4, 2025
Higher Rates of Depression in Polymyalgia Rheumatica Are Strongly Associated With Poor Physical FunctionJessica L Leung, Natalie Deeble, Victor Yang, et al.
Clinical Rheumatology|February 17, 2009
What factors determine patients' preference for tumour necrosis factor inhibitors in ankylosing spondylitis?Dessy W Fajri, Caroline A Brand, Shyamali C Dharmage, et al.
International Journal of Rheumatic Diseases|October 12, 2020
Neutrophil to lymphocyte ratio predicts glucocorticoid resistance in polymyalgia rheumaticaClaire E Owen, Christopher McMaster, David F L Liew, et al.
International Journal of Rheumatic Diseases|December 15, 2018
Association of good oncological response to therapy with the development of rheumatic immune-related adverse events following PD-1 inhibitor therapyDavid F L Liew, Jessica L Y Leung, Bonnia Liu, et al.
Clinical Rheumatology|November 6, 2008
Complementary and alternative medicines in ankylosing spondylitis: a cross-sectional studySimon M Chatfield, Shyamali C Dharmage, Anthony Boers, et al.
Rheumatic Diseases Clinics of North America|April 26, 2024
Immune Checkpoint Inhibitor-induced Polymyalgia RheumaticaDavid F L Liew, Sarah L Mackie, Alice Tison, et al.
Rheumatology Advances in Practice|March 27, 2023
Diagnosis of septic arthritis in the acute care setting: the value of routine intra-operative sample culturePallavi Shamdasani, David F L Liew, Michael Nohrenberg, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Clinical Rheumatology|October 20, 2023
Exploring the patient experience in polymyalgia rheumaticaGeorgia K Harris, Jessica L Leung, Russell R C Buchanan
Clinical Rheumatology|February 2, 2010
Tumour necrosis factor inhibitor-related lupus: safety of switching agentsJessica M T Luong, Boon T Tan, Russell R C Buchanan, et al.
Immunology|May 22, 2003
Soluble FcgammaRIIa inhibits rheumatoid factor binding to immune complexesBruce D Wines, Amanda Gavin, Maree S Powell, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 4, 2025
Higher Rates of Depression in Polymyalgia Rheumatica Are Strongly Associated With Poor Physical FunctionJessica L Leung, Natalie Deeble, Victor Yang, et al.
Clinical Rheumatology|February 17, 2009
What factors determine patients' preference for tumour necrosis factor inhibitors in ankylosing spondylitis?Dessy W Fajri, Caroline A Brand, Shyamali C Dharmage, et al.
International Journal of Rheumatic Diseases|October 12, 2020
Neutrophil to lymphocyte ratio predicts glucocorticoid resistance in polymyalgia rheumaticaClaire E Owen, Christopher McMaster, David F L Liew, et al.
International Journal of Rheumatic Diseases|December 15, 2018
Association of good oncological response to therapy with the development of rheumatic immune-related adverse events following PD-1 inhibitor therapyDavid F L Liew, Jessica L Y Leung, Bonnia Liu, et al.
Clinical Rheumatology|November 6, 2008
Complementary and alternative medicines in ankylosing spondylitis: a cross-sectional studySimon M Chatfield, Shyamali C Dharmage, Anthony Boers, et al.
Rheumatic Diseases Clinics of North America|April 26, 2024
Immune Checkpoint Inhibitor-induced Polymyalgia RheumaticaDavid F L Liew, Sarah L Mackie, Alice Tison, et al.
Rheumatology Advances in Practice|March 27, 2023
Diagnosis of septic arthritis in the acute care setting: the value of routine intra-operative sample culturePallavi Shamdasani, David F L Liew, Michael Nohrenberg, et al.
Pageof 2